GNMK Crosses Above Average Analyst Target
February 12, 2021 at 08:35 AM EST
In recent trading, shares of GenMark Diagnostics, Inc. (GNMK) have crossed above the average analyst 12-month target price of $19.60, changing hands for $22.45/share..